Life ScienceCompany
Genzyme M&A Summary
Genzyme has acquired 17 companies of its own. A total of 9 acquisitions came from private equity firms. It has also divested 3 assets.
Genzyme’s largest acquisition to date was in 2004, when it acquired ILEX Oncology for $1.0B. It’s largest disclosed sale occurred in 2010, when it sold Genzyme Genetics to Laboratory of America Holdings for $925M. Genzyme has acquired in 8 different US states, and 4 countries. The Company’s most targeted sectors include life science (75%) and medical products (25%).
Genzyme Ownership
Who owns Genzyme?
Genzyme is owned by Sanofi SA. It was acquired on February 16, 2011.
Genzyme Business Overview
Where is Genzyme headquartered?
Genzyme is headquartered in Cambridge, Massachusetts.
What sector is Genzyme in?
Genzyme is a life science company.
When was Genzyme founded?
Genzyme was founded in 1981.
M&A Summary
-
M&A Total Activity15
- M&A Buy Activity12
- M&A Sell Activity3
- Total Sectors Invested 2
- Total Countries Invested 4
- M&A Buy/Sell Connections 12
- M&A Advisors 3
Unlimited Searches
